Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Benjamin Dieplinger

Showing results (51-60 of 102) with videos related to

Pageof 11
Sort By:
The European Journal of Neuroscience|December 7, 2007
The transcriptional corepressor TPA-inducible sequence 7 regulates adult axon growth through cellular retinoic acid binding protein II expressionBenjamin Dieplinger, Natalia Schiefermeier, Michaela Juchum-Pasquazzo, et al.
European Journal of Clinical Pharmacology|December 19, 2009
Genetic determinants of acenocoumarol and phenprocoumon maintenance dose requirementsJanne Cadamuro, Benjamin Dieplinger, Thomas Felder, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|December 14, 2011
Prognostic value of soluble ST2 in an unselected cohort of patients admitted to an intensive care unit - The Linz Intensive Care Unit (LICU) studyBenjamin Dieplinger, Margot Egger, Wolfgang Koehler, et al.
Journal of Vascular Surgery|May 12, 2005
Factor V Leiden, prothrombin G20210A, and methylenetetrahydrofolate reductase C677T mutations are not associated with chronic limb ischemia: the Linz Peripheral Arterial Disease (LIPAD) studyThomas Mueller, Renate Marschon, Benjamin Dieplinger, et al.
Clinical Chemistry|May 26, 2007
Increased serum lipoprotein(a) concentrations and low molecular weight phenotypes of apolipoprotein(a) are associated with symptomatic peripheral arterial diseaseBenjamin Dieplinger, Arno Lingenhel, Nadja Baumgartner, et al.
Clinical Chemistry and Laboratory Medicine|July 9, 2008
Influence of hydroxyethyl starch (6% HES 130/0.4) administration on hematology and clinical chemistry parametersThomas Mueller, Wolfgang Schimetta, Benjamin Dieplinger, et al.
Journal of Critical Care|June 12, 2016
Interleukin 6, galectin 3, growth differentiation factor 15, and soluble ST2 for mortality prediction in critically ill patientsBenjamin Dieplinger, Margot Egger, Isabella Leitner, et al.
Journal of Cardiovascular Translational Research|March 22, 2021
Storm of Cardiovascular Markers After LPS Administration in Human VolunteersMichael Resl, Matthias Wolfgang Heinzl, Carmen Klammer, et al.
Clinical Laboratory|July 15, 2014
Circulating heat shock protein 27 as a biomarker for the differentiation of patients with lung cancer and healthy controls--a clinical comparison of different enzyme linked immunosorbent assaysMatthias Zimmermann, Thomas Mueller, Benjamin Dieplinger, et al.
Kidney International|December 5, 2008
Pro-A-type natriuretic peptide and pro-adrenomedullin predict progression of chronic kidney disease: the MMKD StudyBenjamin Dieplinger, Thomas Mueller, Barbara Kollerits, et al.
Pageof 11

Showing results (51-60 of 102) with videos related to

Sort By:
Pageof 11
The European Journal of Neuroscience|December 7, 2007
The transcriptional corepressor TPA-inducible sequence 7 regulates adult axon growth through cellular retinoic acid binding protein II expressionBenjamin Dieplinger, Natalia Schiefermeier, Michaela Juchum-Pasquazzo, et al.
European Journal of Clinical Pharmacology|December 19, 2009
Genetic determinants of acenocoumarol and phenprocoumon maintenance dose requirementsJanne Cadamuro, Benjamin Dieplinger, Thomas Felder, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|December 14, 2011
Prognostic value of soluble ST2 in an unselected cohort of patients admitted to an intensive care unit - The Linz Intensive Care Unit (LICU) studyBenjamin Dieplinger, Margot Egger, Wolfgang Koehler, et al.
Journal of Vascular Surgery|May 12, 2005
Factor V Leiden, prothrombin G20210A, and methylenetetrahydrofolate reductase C677T mutations are not associated with chronic limb ischemia: the Linz Peripheral Arterial Disease (LIPAD) studyThomas Mueller, Renate Marschon, Benjamin Dieplinger, et al.
Clinical Chemistry|May 26, 2007
Increased serum lipoprotein(a) concentrations and low molecular weight phenotypes of apolipoprotein(a) are associated with symptomatic peripheral arterial diseaseBenjamin Dieplinger, Arno Lingenhel, Nadja Baumgartner, et al.
Clinical Chemistry and Laboratory Medicine|July 9, 2008
Influence of hydroxyethyl starch (6% HES 130/0.4) administration on hematology and clinical chemistry parametersThomas Mueller, Wolfgang Schimetta, Benjamin Dieplinger, et al.
Journal of Critical Care|June 12, 2016
Interleukin 6, galectin 3, growth differentiation factor 15, and soluble ST2 for mortality prediction in critically ill patientsBenjamin Dieplinger, Margot Egger, Isabella Leitner, et al.
Journal of Cardiovascular Translational Research|March 22, 2021
Storm of Cardiovascular Markers After LPS Administration in Human VolunteersMichael Resl, Matthias Wolfgang Heinzl, Carmen Klammer, et al.
Clinical Laboratory|July 15, 2014
Circulating heat shock protein 27 as a biomarker for the differentiation of patients with lung cancer and healthy controls--a clinical comparison of different enzyme linked immunosorbent assaysMatthias Zimmermann, Thomas Mueller, Benjamin Dieplinger, et al.
Kidney International|December 5, 2008
Pro-A-type natriuretic peptide and pro-adrenomedullin predict progression of chronic kidney disease: the MMKD StudyBenjamin Dieplinger, Thomas Mueller, Barbara Kollerits, et al.
Pageof 11